etidocaine structure
|
Common Name | etidocaine | ||
|---|---|---|---|---|
| CAS Number | 36637-18-0 | Molecular Weight | 276.417 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 389.7±30.0 °C at 760 mmHg | |
| Molecular Formula | C17H28N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 189.5±24.6 °C | |
Use of etidocaineEtidocaine (EDC) is a long aminoamide local anesthetic[1]. |
| Name | etidocaine |
|---|---|
| Synonym | More Synonyms |
| Description | Etidocaine (EDC) is a long aminoamide local anesthetic[1]. |
|---|---|
| Related Catalog | |
| In Vitro | IGL-EDC formulations can induce a significant increase in human fibroblasts survival[1]. Cell Viability Assay[1] Cell Line: Human fibroblasts cells Concentration: 0, 4, 8, 16, 24 mM Incubation Time: 4, 6 and 24 h Result: Showed that cell survival decreased in a (EDC) concentration with time-dependent manner. |
| In Vivo | Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit[2]. Animal Model: Adult Swiss Webster male mice[2] Dosage: 0.0075% Administration: Etidocaine (spinal injection, 0.0075%, once) Result: Did not show postinjection neurologic deficit. |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 389.7±30.0 °C at 760 mmHg |
| Molecular Formula | C17H28N2O |
| Molecular Weight | 276.417 |
| Flash Point | 189.5±24.6 °C |
| Exact Mass | 276.220154 |
| PSA | 32.34000 |
| LogP | 3.77 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.532 |
| InChIKey | VTUSIVBDOCDNHS-UHFFFAOYSA-N |
| SMILES | CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| (2S)-N-(2,6-Dimethylphenyl)-2-[ethyl(propyl)amino]butanamide |
| Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (2S)- |
| 2-ethylpropylamino-2,6-n-butyroxylidide |
| Etidocaine |